INSIGHTS · 4 MIN READ · BY CannaBless Editorial

Switzerland medical cannabis import pathway: the Swissmedic framework in 2026

How licensed medical cannabis enters Switzerland in 2026 — the Swissmedic narcotics and establishment framework, what a Swiss importer needs, and how Thai-origin supply routes in.

Switzerland medical cannabis import pathway: the Swissmedic framework in 2026

Why Switzerland belongs on a Thai supplier's map

Switzerland moved medical cannabis out of prohibition in August 2022, when an amendment to the Narcotics Act (Betäubungsmittelgesetz / BetmG) lifted the general ban and shifted the product into a Swissmedic-administered authorisation regime.

Physicians can now prescribe cannabis-based medicines without the case-by-case federal exemption that previously gated every prescription. A licensed importer base has grown to meet that demand.

For a licensed Thai buyer or importer evaluating where Thai-origin supply can land, the Swiss map is unusually clean. A single federal regulator gates a two-layer licence structure, and internationally cultivated flower routes through Swiss-licensed importers rather than direct cultivator-to-pharmacy.

This brief outlines the framework at a general level, the documentation a Swiss importer expects on the cultivator side, and how CannaBless — an export brokerage, not an exporter — connects licensed Thai supply into it.

Swissmedic and the two-layer licence structure

Switzerland concentrates medical-cannabis oversight in one federal agency, which keeps the map cleaner than the two-regulator split seen in the UK import pathway. Two licence layers sit under Swissmedic.

Establishment licence (Betriebsbewilligung). Any Swiss party that handles narcotics — importing, storing, processing, or wholesaling cannabis — must hold a Swissmedic establishment licence covering those activities. This is the standing licence that qualifies an importer to operate at all.

Shipment-specific narcotics import authorisation. Cannabis remains a controlled substance under the BetmG. Each individual consignment requires a Swissmedic import authorisation naming the consignor, consignee, quantity, and product form, aligned with the International Narcotics Control Board reporting framework that governs cross-border narcotics movement worldwide.

The licensed Swiss importer holds both. The Thai cultivation farm does not, and does not need to. The importer assumes the Swiss regulatory burden, and the farm supplies clean, documentation-complete material into it.

What a Swiss importer verifies before sourcing

Swissmedic expects imported medical cannabis to be produced under Good Manufacturing Practice conditions recognised for the Swiss market, so the diligence a Swiss importer runs mirrors the German BfArM pathway closely.

In practice the cultivator-side pack a Swiss importer asks for includes:

Swiss importers read this pack carefully. A CoA that reports cannabinoids without a quantified per-terpene breakdown meets the same scepticism it draws in the German market.

Where the Thai supply side sits

The Thai export side rests on the six DTAM export-eligible categories under Ministerial Regulation No. 2 B.E. 2569 — hospitals under the Sanatorium Act; herbal-product manufacturing or sales licence holders; drug manufacturing or sales licence holders; Category-5 narcotics (cannabis and hemp extract) licence holders; certified traditional healers; and cultivation sites supplying licensed buyers.

Most farms CannaBless represents hold the sixth status and sell into a licensed downstream party. The framework and what a foreign importer should verify is covered in full in our brief on what changed for Thai export in 2026.

Supply is also finite, which matters to a buyer weighing whether to build a Thai channel. The DTAM register recorded roughly 79 GACP-certified operators as at 16 July 2025 — a narrow certified base, which is why importers who move early tend to secure the cleaner documentation histories.

A note for investors reading this

Foreign participation in a Thai cultivation operation is a matter of lawful joint-venture or BOI-promoted investment structuring, never nominee arrangements. Nominee shareholding is a criminal offence under the Thai Foreign Business Act §36, carrying penalties for both the foreign party and the Thai nominee.

The supply side of a Swiss deal is built on farms whose licence and ownership positions withstand exactly that scrutiny. This is not legal advice — confirm any structure with Thai counsel.

How CannaBless approaches Swiss supply conversations

CannaBless is a Thailand-based, cultivator-side export brokerage. We register and document the licensed Thai farms we represent, facilitate their export-licensing documentation, and connect them to licensed Swiss importers operating under Swissmedic establishment and import authorisations.

We do not hold Swiss licences, and we do not intend to — that is the importer's domain. We do not sell to Swiss physicians, pharmacies, or patients, and this brief carries no medical or dosing guidance.

Our role is to ensure the farms we represent deliver GACP-certified, ISO/IEC 17025-tested, cold-chain-documented Thai flower, backed by a complete documentation pack, so a Swiss importer can file its narcotics import authorisation cleanly.

The consignment of 700 kg of Cannabis Sativa L. under import permit IT-20261155773424 — phytosanitary-certified and GACP-aligned, arriving Genova in June 2026 — is the live proof anchor. It demonstrates that the cultivator side of this exact documentation pattern already operates. A Swiss conversation begins from the same base.

Talk to us

If you are a Swiss-licensed medical cannabis importer or wholesaler evaluating Thai-origin supply, the export desk responds within one business day from Bangkok (UTC+7).

We share licence-stack references, DTAM training records, and TH-GACP certification without asking for an LOI first — the documentation is what earns the conversation, so we would rather you have it in hand.

Related briefings

Looking to begin a regulated supply conversation? Reach the export desk →